Synthetic routes to pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-diones are disclosed and examples for their subsequent transformations into cyclometalated protein kinase inhibitors are presented.
No takes yet. Share an insight, caveat, or question.
Meggers et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: